Your browser doesn't support javascript.
loading
Lymphocytes, Interleukin 6 and D-dimer Cannot Predict Clinical Outcome in Coronavirus Cancer Patients: LyNC1.20 Study.
Vanni, Gianluca; Materazzo, Marco; Dauri, Mario; Farinaccio, Andrea; Buonomo, Chiara; Portarena, Ilaria; Pellicciaro, Marco; Legramante, Jacopo Maria; Rizza, Stefano; Chiaramonte, Carlo; Bellia, Alfonso; Grande, Michele; Potenza, Saverio; Sbordone, Francesco Paolo; Perrone, Marco Alfonso; Grimaldi, Francesco; Chiocchi, Marcello; Buonomo, Oreste Claudio.
Affiliation
  • Vanni G; Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy; vanni_gianluca@yahoo.it.
  • Materazzo M; Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.
  • Dauri M; Department of Emergency and Admission, Critical Care Medicine, Pain Medicine and Anesthetic Science, Policlinico Tor Vergata University, Rome, Italy.
  • Farinaccio A; Department of Emergency and Admission, Critical Care Medicine, Pain Medicine and Anesthetic Science, Policlinico Tor Vergata University, Rome, Italy.
  • Buonomo C; Department of Emergency and Admission, Critical Care Medicine, Pain Medicine and Anesthetic Science, Policlinico Tor Vergata University, Rome, Italy.
  • Portarena I; Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.
  • Pellicciaro M; Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.
  • Legramante JM; Emergency Department, Tor Vergata University Hospital, Rome, Italy.
  • Rizza S; Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
  • Chiaramonte C; Department of Emergency and Admission, Critical Care Medicine, Pain Medicine and Anesthetic Science, Policlinico Tor Vergata University, Rome, Italy.
  • Bellia A; Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
  • Grande M; Department of General and Emergency Surgery, University of Tor Vergata, Rome, Italy.
  • Potenza S; Department of Biomedicine and Prevention, Section of Legal Medicine, Social Security and Forensic Toxicology, University of Rome Tor Vergata, Rome, Italy.
  • Sbordone FP; Department of Biomedicine and Prevention, Division of Diagnostic Imaging, University of Rome Tor Vergata, Rome, Italy.
  • Perrone MA; Division of Cardiology, University of Rome Tor Vergata, Rome, Italy.
  • Grimaldi F; Department of Biomedicine and Prevention, Division of Diagnostic Imaging, University of Rome Tor Vergata, Rome, Italy.
  • Chiocchi M; Department of Biomedicine and Prevention, Division of Diagnostic Imaging, University of Rome Tor Vergata, Rome, Italy.
  • Buonomo OC; Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.
Anticancer Res ; 41(1): 307-316, 2021 Jan.
Article in En | MEDLINE | ID: mdl-33419825
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fibrin Fibrinogen Degradation Products / Lymphocytes / Interleukin-6 / Coronavirus Infections / Coronavirus / Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Anticancer Res Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fibrin Fibrinogen Degradation Products / Lymphocytes / Interleukin-6 / Coronavirus Infections / Coronavirus / Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Anticancer Res Year: 2021 Type: Article